Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:16 pm Purchase |
2024-09-30 | 13G | Presidio Property Trust, Inc. SQFT |
Armistice Capital, LLC | 1,612,825 9.990% |
155,564 (+10.68%) |
Filing History |
| 2024-11-14 5:15 pm Purchase |
2024-09-30 | 13G | Mural Oncology plc MURA |
Armistice Capital, LLC | 1,700,000 9.980% |
42,000 (+2.53%) |
Filing History |
| 2024-11-14 5:15 pm Purchase |
2024-09-30 | 13G | Staffing 360 Solutions, Inc. STAF |
Armistice Capital, LLC | 105,610 9.990% |
105,610 (New Position) |
Filing History |
| 2024-11-14 5:14 pm Unchanged |
2024-09-30 | 13G | Momentus Inc. MNTS |
Armistice Capital, LLC | 202,476 9.990% |
0 (Unchanged) |
Filing History |
| 2024-11-14 5:14 pm Purchase |
2024-09-30 | 13G | Supernus Pharmaceuticals, Inc. SUPN |
Armistice Capital, LLC | 5,096,000 9.250% |
446,000 (+9.59%) |
Filing History |
| 2024-11-14 5:14 pm Purchase |
2024-09-30 | 13G | Momentus Inc. MNTS |
Armistice Capital, LLC | 202,476 9.990% |
167,334 (+476.15%) |
Filing History |
| 2024-11-14 5:13 pm Purchase |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
Armistice Capital, LLC | 7,648,000 10.000% |
264,000 (+3.58%) |
Filing History |
| 2024-11-14 5:13 pm Purchase |
2024-09-30 | 13G | MacroGenics, Inc. MGNX |
Armistice Capital, LLC | 6,258,000 9.980% |
1,686,000 (+36.88%) |
Filing History |
| 2024-11-14 5:12 pm Purchase |
2024-09-30 | 13G | Catheter Precision, Inc. VTAK |
Armistice Capital, LLC | 105,743 9.990% |
105,743 (New Position) |
Filing History |
| 2024-11-14 5:12 pm Purchase |
2024-09-30 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 5,200,000 9.540% |
964,000 (+22.76%) |
Filing History |
| 2024-11-14 5:12 pm Purchase |
2024-09-30 | 13G | Moleculin Biotech, Inc. MBRX |
Armistice Capital, LLC | 300,988 9.990% |
300,988 (New Position) |
Filing History |
| 2024-11-14 5:10 pm Sale |
2024-09-30 | 13G | GeoVax Labs, Inc. GOVX |
Armistice Capital, LLC | 946,137 9.990% |
-2,164,932 (-69.59%) |
Filing History |
| 2024-11-14 5:08 pm Purchase |
2024-09-30 | 13G | Eyenovia, Inc. EYEN |
Armistice Capital, LLC | 107,500 9.950% |
52,775 (+96.44%) |
Filing History |
| 2024-11-14 5:07 pm Purchase |
2024-09-30 | 13G | Dermata Therapeutics, Inc. DRMA |
Armistice Capital, LLC | 186,211 9.990% |
186,211 (New Position) |
Filing History |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
Armistice Capital, LLC | 1,313,348 9.990% |
234,889 (+21.78%) |
Filing History |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | BIO-key International, Inc. BKYI |
Armistice Capital, LLC | 250,000 8.950% |
128,506 (+105.77%) |
Filing History |
| 2024-11-14 5:03 pm Purchase |
2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS |
Armistice Capital, LLC | 319,756 9.990% |
319,756 (New Position) |
Filing History |
| 2024-11-14 5:01 pm Purchase |
2024-09-30 | 13G | Worksport Ltd. WKSP |
Armistice Capital, LLC | 309,777 9.990% |
103,188 (+49.95%) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | T Stamp Inc. IDAI |
Armistice Capital, LLC | 134,886 9.990% |
72,406 (+115.89%) |
Filing History |
| 2024-11-14 4:52 pm Sale |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
Armistice Capital, LLC | 6,800,000 6.770% |
-2,964,000 (-30.36%) |
Filing History |